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&ge from diffuse disease and multiple sites of arrhythmia 
initiation ( ,sj, conditions that could foil catheter ablation as 
we& Therefore, important differences of the arrhythmia char- 
acteristics in th2 patients reated may account for the unex- 
pectedly high success ;ate of catheter techniques. The single 
failure of Walsh et al. (91 supports his possibility and provides 
evidence that operative methods continue to have a role in the 
management of this disorder. 
Role of pharmacologic therapy. Despite the success and 
appeal of catheter and operative ablation, efforts to improve 
pharmacologic therapy should not be abandoned because 
such treatment may be preferred in cases when prompt 
control is needed, the arrhythmia may be transient (131, 
invasive procedures are unsafe, multiple foci require sup- 
pression or new foci develop over months or years (1,5). 
Furthermore, r ports of dramatic responses toa varieiy of 
antiarrhythmic agents uch as flecainide (14), sotalol (1% 
verapamil (16) and adenosine (17) could justify a trial of 
pharmacotherapy in some patients. Hcwever, the limited 
overall response to rlrugs in current use suggests hat new 
approaches may be required. 
Different arrhylhmia mechanisms probably exist among 
the arrhythmias classified as ectopic atria1 tachycardia, but 
the similarity to sinus rhythm among some may have prac- 
tical significance. Like sinus rhythm, the rate of ectopic 
atria1 tachycardia may increase or decrease inresponse to 
alterations in autonomic a tivity (18-20); asimilar resetting 
response has been observed in some cases (19) and both 
rhythms tend to have very robust pacemaker mechanisms 
that respond minimally to conventional ntiarrhythmic 
drugs. The two rhythms may also have a common ancestry: 
The sinus node develops inassociation with vascular struc- 
tures at the venous end of the primordial cardiac tube (21), 
whereas many cases of ectopic atrial tachycardia appear to 
arise in association with vascular tissue such as the pulmo- 
nary veins (2). Thus, the pacemaker processes may be 
descendants of pontaneous electrical ctivity that occurs in 
some veins (22). It may therefore be possible to use readily 
available sinus node preparations and mathematic models of 
sinus rhythm to develop antiarrhythmic drugs to control 
ectopic atrial tachycardia. Furthermore, complete suppres- 
sion is not necessary if the rate of ectopic atria1 tachycardia 
can be lowered to physiologic levels. 
Implications. The correct approach ina given case must 
be based on the characteristics of the individual patient, he 
short-term and long-term safety and costs of the various 
methods and the expertise that is available. Beyond these 
usual considerations it is tempting to recommend catheier 
ablation as the therapy of first choice given the low yield and 
potential dangers of long-term ,:*erapy with available anti- 
arrhythmic drugs and the greater morbidity associated with 
OPePatiVe treatmet& However, the experience with radio- 
frequency catheter abiattzn for this indication islimited and 
current published accounts may not reflect wide application 
of the technique. There remains a need for other therapeutic 
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options and in this regard Pr,ger and colleagues are to be 
congrattilated for their perseverance indevelo 
ative approach. We look forward to new in 
their sophisiicated intraoperative studies t 
improvements in ail modes of therapy. 
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